nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—Vismodegib—skin cancer	0.153	0.195	CbGbCtD
Tolterodine—CYP2C9—Vismodegib—skin cancer	0.128	0.162	CbGbCtD
Tolterodine—CYP3A4—Imiquimod—skin cancer	0.107	0.136	CbGbCtD
Tolterodine—CYP3A4—Temozolomide—skin cancer	0.107	0.136	CbGbCtD
Tolterodine—CYP2D6—Vemurafenib—skin cancer	0.0922	0.117	CbGbCtD
Tolterodine—CYP3A4—Vismodegib—skin cancer	0.0742	0.0944	CbGbCtD
Tolterodine—CYP3A4—Vemurafenib—skin cancer	0.0587	0.0747	CbGbCtD
Tolterodine—CYP2C9—Fluorouracil—skin cancer	0.0453	0.0577	CbGbCtD
Tolterodine—CYP3A4—Docetaxel—skin cancer	0.0201	0.0256	CbGbCtD
Tolterodine—Influenza-like symptoms—Imiquimod—skin cancer	0.00562	0.0271	CcSEcCtD
Tolterodine—Gastrooesophageal reflux disease—Imiquimod—skin cancer	0.00444	0.0214	CcSEcCtD
Tolterodine—Influenza like illness—Imiquimod—skin cancer	0.0039	0.0188	CcSEcCtD
Tolterodine—Influenza-like symptoms—Temozolomide—skin cancer	0.00337	0.0163	CcSEcCtD
Tolterodine—Dry skin—Vemurafenib—skin cancer	0.00313	0.0151	CcSEcCtD
Tolterodine—Memory impairment—Temozolomide—skin cancer	0.00306	0.0148	CcSEcCtD
Tolterodine—Arthralgia—Vismodegib—skin cancer	0.00284	0.0137	CcSEcCtD
Tolterodine—Urinary retention—Imiquimod—skin cancer	0.00277	0.0134	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00248	0.012	CcSEcCtD
Tolterodine—Bronchitis—Imiquimod—skin cancer	0.00242	0.0117	CcSEcCtD
Tolterodine—Dyspepsia—Vismodegib—skin cancer	0.00239	0.0115	CcSEcCtD
Tolterodine—Dysuria—Imiquimod—skin cancer	0.00235	0.0114	CcSEcCtD
Tolterodine—Fatigue—Vismodegib—skin cancer	0.00234	0.0113	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00234	0.0113	CcSEcCtD
Tolterodine—Influenza like illness—Temozolomide—skin cancer	0.00234	0.0113	CcSEcCtD
Tolterodine—Oedema peripheral—Vemurafenib—skin cancer	0.00233	0.0112	CcSEcCtD
Tolterodine—Constipation—Vismodegib—skin cancer	0.00232	0.0112	CcSEcCtD
Tolterodine—Pain—Vismodegib—skin cancer	0.00232	0.0112	CcSEcCtD
Tolterodine—Disorientation—Bleomycin—skin cancer	0.00231	0.0112	CcSEcCtD
Tolterodine—Gastrointestinal pain—Vismodegib—skin cancer	0.00222	0.0107	CcSEcCtD
Tolterodine—Dry eye—Temozolomide—skin cancer	0.00222	0.0107	CcSEcCtD
Tolterodine—Urinary tract infection—Imiquimod—skin cancer	0.00218	0.0105	CcSEcCtD
Tolterodine—Abdominal pain—Vismodegib—skin cancer	0.00215	0.0104	CcSEcCtD
Tolterodine—CHRM3—muscle of abdomen—skin cancer	0.00213	0.298	CbGeAlD
Tolterodine—Sinusitis—Imiquimod—skin cancer	0.00211	0.0102	CcSEcCtD
Tolterodine—Abnormal vision—Temozolomide—skin cancer	0.0021	0.0101	CcSEcCtD
Tolterodine—Asthenia—Vismodegib—skin cancer	0.00195	0.00941	CcSEcCtD
Tolterodine—Visual impairment—Imiquimod—skin cancer	0.00194	0.00938	CcSEcCtD
Tolterodine—Flushing—Imiquimod—skin cancer	0.00187	0.00903	CcSEcCtD
Tolterodine—Diarrhoea—Vismodegib—skin cancer	0.00186	0.00898	CcSEcCtD
Tolterodine—Disorientation—Fluorouracil—skin cancer	0.0018	0.00868	CcSEcCtD
Tolterodine—Arthralgia—Vemurafenib—skin cancer	0.00175	0.00845	CcSEcCtD
Tolterodine—Anaphylactic shock—Vemurafenib—skin cancer	0.00168	0.0081	CcSEcCtD
Tolterodine—Infection—Vemurafenib—skin cancer	0.00167	0.00805	CcSEcCtD
Tolterodine—Angioedema—Imiquimod—skin cancer	0.0016	0.00774	CcSEcCtD
Tolterodine—Dry skin—Temozolomide—skin cancer	0.0016	0.00772	CcSEcCtD
Tolterodine—Influenza like illness—Docetaxel—skin cancer	0.00155	0.0075	CcSEcCtD
Tolterodine—Palpitations—Imiquimod—skin cancer	0.00155	0.00748	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00153	0.00738	CcSEcCtD
Tolterodine—Arthralgia—Imiquimod—skin cancer	0.00149	0.00721	CcSEcCtD
Tolterodine—Chest pain—Imiquimod—skin cancer	0.00149	0.00721	CcSEcCtD
Tolterodine—Anxiety—Imiquimod—skin cancer	0.00149	0.00719	CcSEcCtD
Tolterodine—Dry skin—Fluorouracil—skin cancer	0.00147	0.00712	CcSEcCtD
Tolterodine—Dry mouth—Imiquimod—skin cancer	0.00146	0.00705	CcSEcCtD
Tolterodine—Bronchitis—Temozolomide—skin cancer	0.00145	0.00701	CcSEcCtD
Tolterodine—Fatigue—Vemurafenib—skin cancer	0.00145	0.00699	CcSEcCtD
Tolterodine—Constipation—Vemurafenib—skin cancer	0.00144	0.00693	CcSEcCtD
Tolterodine—Oedema—Imiquimod—skin cancer	0.00143	0.00691	CcSEcCtD
Tolterodine—Infection—Imiquimod—skin cancer	0.00142	0.00687	CcSEcCtD
Tolterodine—Dysuria—Temozolomide—skin cancer	0.00141	0.00681	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Temozolomide—skin cancer	0.0014	0.00677	CcSEcCtD
Tolterodine—Tachycardia—Imiquimod—skin cancer	0.0014	0.00675	CcSEcCtD
Tolterodine—CHRM5—skin epidermis—skin cancer	0.00139	0.195	CbGeAlD
Tolterodine—Weight increased—Temozolomide—skin cancer	0.00137	0.00663	CcSEcCtD
Tolterodine—Flushing—Bleomycin—skin cancer	0.00133	0.00641	CcSEcCtD
Tolterodine—Urinary tract infection—Temozolomide—skin cancer	0.00131	0.00631	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.0013	0.0063	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00129	0.00624	CcSEcCtD
Tolterodine—Somnolence—Imiquimod—skin cancer	0.00127	0.00614	CcSEcCtD
Tolterodine—Sinusitis—Temozolomide—skin cancer	0.00126	0.00609	CcSEcCtD
Tolterodine—Dyspepsia—Imiquimod—skin cancer	0.00126	0.00608	CcSEcCtD
Tolterodine—Flushing—Dactinomycin—skin cancer	0.00124	0.00598	CcSEcCtD
Tolterodine—Hypersensitivity—Vemurafenib—skin cancer	0.00124	0.00597	CcSEcCtD
Tolterodine—Fatigue—Imiquimod—skin cancer	0.00123	0.00596	CcSEcCtD
Tolterodine—Pain—Imiquimod—skin cancer	0.00122	0.00591	CcSEcCtD
Tolterodine—Urinary tract infection—Fluorouracil—skin cancer	0.00121	0.00582	CcSEcCtD
Tolterodine—Asthenia—Vemurafenib—skin cancer	0.0012	0.00582	CcSEcCtD
Tolterodine—Hallucination—Temozolomide—skin cancer	0.0012	0.0058	CcSEcCtD
Tolterodine—Oedema peripheral—Temozolomide—skin cancer	0.00119	0.00574	CcSEcCtD
Tolterodine—Feeling abnormal—Imiquimod—skin cancer	0.00118	0.0057	CcSEcCtD
Tolterodine—Gastrointestinal pain—Imiquimod—skin cancer	0.00117	0.00565	CcSEcCtD
Tolterodine—Visual impairment—Temozolomide—skin cancer	0.00116	0.00562	CcSEcCtD
Tolterodine—Sinusitis—Fluorouracil—skin cancer	0.00116	0.00561	CcSEcCtD
Tolterodine—Diarrhoea—Vemurafenib—skin cancer	0.00115	0.00555	CcSEcCtD
Tolterodine—Abdominal pain—Imiquimod—skin cancer	0.00113	0.00546	CcSEcCtD
Tolterodine—Flushing—Temozolomide—skin cancer	0.00112	0.00541	CcSEcCtD
Tolterodine—Dizziness—Vemurafenib—skin cancer	0.00111	0.00536	CcSEcCtD
Tolterodine—Dry skin—Docetaxel—skin cancer	0.00106	0.00514	CcSEcCtD
Tolterodine—Chest pain—Bleomycin—skin cancer	0.00106	0.00512	CcSEcCtD
Tolterodine—Hypersensitivity—Imiquimod—skin cancer	0.00105	0.00509	CcSEcCtD
Tolterodine—Headache—Vemurafenib—skin cancer	0.00105	0.00508	CcSEcCtD
Tolterodine—Asthenia—Imiquimod—skin cancer	0.00103	0.00496	CcSEcCtD
Tolterodine—Confusional state—Bleomycin—skin cancer	0.00103	0.00495	CcSEcCtD
Tolterodine—Oedema—Bleomycin—skin cancer	0.00102	0.00491	CcSEcCtD
Tolterodine—Anaphylactic shock—Bleomycin—skin cancer	0.00102	0.00491	CcSEcCtD
Tolterodine—Infection—Bleomycin—skin cancer	0.00101	0.00488	CcSEcCtD
Tolterodine—Diarrhoea—Imiquimod—skin cancer	0.00098	0.00473	CcSEcCtD
Tolterodine—Angioedema—Temozolomide—skin cancer	0.000961	0.00464	CcSEcCtD
Tolterodine—Oedema—Dactinomycin—skin cancer	0.000949	0.00458	CcSEcCtD
Tolterodine—Dizziness—Imiquimod—skin cancer	0.000947	0.00457	CcSEcCtD
Tolterodine—Vertigo—Temozolomide—skin cancer	0.000945	0.00456	CcSEcCtD
Tolterodine—Infection—Dactinomycin—skin cancer	0.000943	0.00455	CcSEcCtD
Tolterodine—Palpitations—Temozolomide—skin cancer	0.000929	0.00449	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000927	0.00447	CcSEcCtD
Tolterodine—Weight increased—Docetaxel—skin cancer	0.000913	0.00441	CcSEcCtD
Tolterodine—Headache—Imiquimod—skin cancer	0.000897	0.00433	CcSEcCtD
Tolterodine—Arthralgia—Temozolomide—skin cancer	0.000895	0.00432	CcSEcCtD
Tolterodine—Anxiety—Temozolomide—skin cancer	0.000892	0.00431	CcSEcCtD
Tolterodine—Dry mouth—Temozolomide—skin cancer	0.000875	0.00423	CcSEcCtD
Tolterodine—Pain—Bleomycin—skin cancer	0.00087	0.0042	CcSEcCtD
Tolterodine—Confusional state—Temozolomide—skin cancer	0.000865	0.00418	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000864	0.00417	CcSEcCtD
Tolterodine—Anaphylactic shock—Temozolomide—skin cancer	0.000858	0.00414	CcSEcCtD
Tolterodine—Oedema—Temozolomide—skin cancer	0.000858	0.00414	CcSEcCtD
Tolterodine—Infection—Temozolomide—skin cancer	0.000853	0.00412	CcSEcCtD
Tolterodine—Feeling abnormal—Bleomycin—skin cancer	0.000838	0.00405	CcSEcCtD
Tolterodine—Chest pain—Fluorouracil—skin cancer	0.000825	0.00398	CcSEcCtD
Tolterodine—Fatigue—Dactinomycin—skin cancer	0.000818	0.00395	CcSEcCtD
Tolterodine—Pain—Dactinomycin—skin cancer	0.000811	0.00392	CcSEcCtD
Tolterodine—Confusional state—Fluorouracil—skin cancer	0.000797	0.00385	CcSEcCtD
Tolterodine—Oedema peripheral—Docetaxel—skin cancer	0.000791	0.00382	CcSEcCtD
Tolterodine—Oedema—Fluorouracil—skin cancer	0.000791	0.00382	CcSEcCtD
Tolterodine—Anaphylactic shock—Fluorouracil—skin cancer	0.000791	0.00382	CcSEcCtD
Tolterodine—Infection—Fluorouracil—skin cancer	0.000785	0.00379	CcSEcCtD
Tolterodine—Feeling abnormal—Dactinomycin—skin cancer	0.000782	0.00377	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000782	0.00377	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000776	0.00374	CcSEcCtD
Tolterodine—Visual impairment—Docetaxel—skin cancer	0.000774	0.00374	CcSEcCtD
Tolterodine—Tachycardia—Fluorouracil—skin cancer	0.000772	0.00372	CcSEcCtD
Tolterodine—Somnolence—Temozolomide—skin cancer	0.000763	0.00368	CcSEcCtD
Tolterodine—Dyspepsia—Temozolomide—skin cancer	0.000755	0.00365	CcSEcCtD
Tolterodine—Abdominal pain—Dactinomycin—skin cancer	0.00075	0.00362	CcSEcCtD
Tolterodine—Hypersensitivity—Bleomycin—skin cancer	0.000749	0.00362	CcSEcCtD
Tolterodine—Flushing—Docetaxel—skin cancer	0.000745	0.0036	CcSEcCtD
Tolterodine—Fatigue—Temozolomide—skin cancer	0.00074	0.00357	CcSEcCtD
Tolterodine—Pain—Temozolomide—skin cancer	0.000734	0.00354	CcSEcCtD
Tolterodine—Constipation—Temozolomide—skin cancer	0.000734	0.00354	CcSEcCtD
Tolterodine—Asthenia—Bleomycin—skin cancer	0.00073	0.00352	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00072	0.00348	CcSEcCtD
Tolterodine—Feeling abnormal—Temozolomide—skin cancer	0.000707	0.00341	CcSEcCtD
Tolterodine—Somnolence—Fluorouracil—skin cancer	0.000703	0.00339	CcSEcCtD
Tolterodine—Gastrointestinal pain—Temozolomide—skin cancer	0.000702	0.00339	CcSEcCtD
Tolterodine—Hypersensitivity—Dactinomycin—skin cancer	0.000699	0.00337	CcSEcCtD
Tolterodine—Dyspepsia—Fluorouracil—skin cancer	0.000696	0.00336	CcSEcCtD
Tolterodine—Asthenia—Dactinomycin—skin cancer	0.000681	0.00329	CcSEcCtD
Tolterodine—Abdominal pain—Temozolomide—skin cancer	0.000678	0.00327	CcSEcCtD
Tolterodine—Pain—Fluorouracil—skin cancer	0.000676	0.00326	CcSEcCtD
Tolterodine—Feeling abnormal—Fluorouracil—skin cancer	0.000652	0.00314	CcSEcCtD
Tolterodine—Diarrhoea—Dactinomycin—skin cancer	0.000649	0.00313	CcSEcCtD
Tolterodine—Hypersensitivity—Temozolomide—skin cancer	0.000632	0.00305	CcSEcCtD
Tolterodine—Palpitations—Docetaxel—skin cancer	0.000618	0.00298	CcSEcCtD
Tolterodine—Asthenia—Temozolomide—skin cancer	0.000616	0.00297	CcSEcCtD
Tolterodine—Arthralgia—Docetaxel—skin cancer	0.000595	0.00287	CcSEcCtD
Tolterodine—Chest pain—Docetaxel—skin cancer	0.000595	0.00287	CcSEcCtD
Tolterodine—Diarrhoea—Temozolomide—skin cancer	0.000587	0.00283	CcSEcCtD
Tolterodine—Hypersensitivity—Fluorouracil—skin cancer	0.000583	0.00281	CcSEcCtD
Tolterodine—Dry mouth—Docetaxel—skin cancer	0.000582	0.00281	CcSEcCtD
Tolterodine—Confusional state—Docetaxel—skin cancer	0.000575	0.00278	CcSEcCtD
Tolterodine—Oedema—Docetaxel—skin cancer	0.000571	0.00275	CcSEcCtD
Tolterodine—Anaphylactic shock—Docetaxel—skin cancer	0.000571	0.00275	CcSEcCtD
Tolterodine—Dizziness—Temozolomide—skin cancer	0.000567	0.00274	CcSEcCtD
Tolterodine—Infection—Docetaxel—skin cancer	0.000567	0.00274	CcSEcCtD
Tolterodine—Tachycardia—Docetaxel—skin cancer	0.000557	0.00269	CcSEcCtD
Tolterodine—Diarrhoea—Fluorouracil—skin cancer	0.000541	0.00261	CcSEcCtD
Tolterodine—Headache—Temozolomide—skin cancer	0.000538	0.00259	CcSEcCtD
Tolterodine—Dizziness—Fluorouracil—skin cancer	0.000523	0.00252	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00052	0.00251	CcSEcCtD
Tolterodine—Somnolence—Docetaxel—skin cancer	0.000507	0.00245	CcSEcCtD
Tolterodine—Dyspepsia—Docetaxel—skin cancer	0.000502	0.00242	CcSEcCtD
Tolterodine—Headache—Fluorouracil—skin cancer	0.000495	0.00239	CcSEcCtD
Tolterodine—Fatigue—Docetaxel—skin cancer	0.000492	0.00237	CcSEcCtD
Tolterodine—Constipation—Docetaxel—skin cancer	0.000488	0.00236	CcSEcCtD
Tolterodine—Pain—Docetaxel—skin cancer	0.000488	0.00236	CcSEcCtD
Tolterodine—Feeling abnormal—Docetaxel—skin cancer	0.00047	0.00227	CcSEcCtD
Tolterodine—Gastrointestinal pain—Docetaxel—skin cancer	0.000467	0.00225	CcSEcCtD
Tolterodine—CHRM5—epithelium—skin cancer	0.000454	0.0635	CbGeAlD
Tolterodine—Abdominal pain—Docetaxel—skin cancer	0.000451	0.00218	CcSEcCtD
Tolterodine—CHRM5—skin of body—skin cancer	0.000432	0.0604	CbGeAlD
Tolterodine—Hypersensitivity—Docetaxel—skin cancer	0.00042	0.00203	CcSEcCtD
Tolterodine—Asthenia—Docetaxel—skin cancer	0.000409	0.00198	CcSEcCtD
Tolterodine—Diarrhoea—Docetaxel—skin cancer	0.00039	0.00188	CcSEcCtD
Tolterodine—Dizziness—Docetaxel—skin cancer	0.000377	0.00182	CcSEcCtD
Tolterodine—CHRM4—head—skin cancer	0.00036	0.0504	CbGeAlD
Tolterodine—Headache—Docetaxel—skin cancer	0.000357	0.00173	CcSEcCtD
Tolterodine—KCNH2—nipple—skin cancer	0.000334	0.0468	CbGeAlD
Tolterodine—CHRM5—head—skin cancer	0.000282	0.0394	CbGeAlD
Tolterodine—CHRM1—female reproductive system—skin cancer	0.000211	0.0295	CbGeAlD
Tolterodine—CHRM2—head—skin cancer	0.000193	0.0271	CbGeAlD
Tolterodine—CHRM3—female reproductive system—skin cancer	0.000189	0.0264	CbGeAlD
Tolterodine—CHRM1—head—skin cancer	0.000176	0.0246	CbGeAlD
Tolterodine—KCNH2—female reproductive system—skin cancer	0.000167	0.0234	CbGeAlD
Tolterodine—CHRM3—head—skin cancer	0.000158	0.022	CbGeAlD
Tolterodine—KCNH2—head—skin cancer	0.00014	0.0195	CbGeAlD
Tolterodine—CYP2C9—female reproductive system—skin cancer	0.000136	0.019	CbGeAlD
Tolterodine—CYP3A4—female reproductive system—skin cancer	0.000104	0.0145	CbGeAlD
Tolterodine—CYP2D6—female reproductive system—skin cancer	0.000102	0.0143	CbGeAlD
Tolterodine—KCNH2—lymph node—skin cancer	9.78e-05	0.0137	CbGeAlD
Tolterodine—CYP2D6—head—skin cancer	8.52e-05	0.0119	CbGeAlD
